UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$237.77 USD
-11.79 (-4.72%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $237.50 -0.27 (-0.11%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
UNH 237.77 -11.79(-4.72%)
Will UNH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for UNH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UNH
Stock Market News for Jul 30, 2025
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
UNH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Trade Deficit Comes in Lower Than Expected
Pre-Markets Up Again on Big News Morning
Here's What Key Metrics Tell Us About UnitedHealth (UNH) Q2 Earnings
Other News for UNH
UnitedHealth: Everyone Is Overreacting
UnitedHealth Group: Buy This Falling Knife - Raised 2026 Premiums Trigger Recovery Prospects
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Bernstein Adjusts Price Target for UnitedHealth (UNH), Maintains Outperform Rating
UnitedHealth price target lowered by $40 at Bernstein, here's why